First-Half 2009 Results

09 September, 2009

bioMérieux, a world leader in the field of in vitro diagnostics, today released its interim financial report for the six months ended June 30, 2009.

Growth in sales:
10.3 % - At constant exchange rates, including business development agreements
6.0 % - At constant exchange rates and scope of consolidation
Growth in operating results before non-recurring items: 16 %